Skip to content
ppharmaranks
Menu
Class IIOngoing

Haloperidol Decanoate Injection recall

FDA recall D-0358-2025 · initiated Mar 21, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Apr 16, 2025How we research

Somerset Therapeutics Private Limited recalled Haloperidol Decanoate Injection in Mar 2025 — an FDA Class II recall (D-0358-2025) because Lack of Assurance of Sterility: Media fill with bacterial contamination.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Lack of Assurance of Sterility: Media fill with bacterial contamination

Sterility could not be assured

The maker could not guarantee the product was sterile. That matters most for injections and eye products, where a contaminated dose reaches past the body's defences.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

A240482D, exp. date 08/2026

Quantity recalled: 240 vials

Details

Product
Haloperidol Decanoate Injection, 100 mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-383-10
Recalling company
Somerset Therapeutics Private Limited
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide
Initiated
Mar 21, 2025
FDA report date
Apr 16, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Haloperidol Decanoate Injection recalled?
Somerset Therapeutics Private Limited recalled Haloperidol Decanoate Injection in Mar 2025 — an FDA Class II recall (D-0358-2025) because Lack of Assurance of Sterility: Media fill with bacterial contamination. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Haloperidol Decanoate Injection recalled?
Per the FDA enforcement record, the reason for recall D-0358-2025 was: Lack of Assurance of Sterility: Media fill with bacterial contamination
Is a recalled Haloperidol Decanoate Injection dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Haloperidol Decanoate Injection are affected?
Distributed: U.S. Nationwide. The recall covers these lots — A240482D, exp. date 08/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0358-2025.

Source: openFDA Drug Enforcement record D-0358-2025

← All drug recalls